Pulse Biosciences (PLSE) Other financing activities (2017 - 2025)

Pulse Biosciences' Other financing activities history runs 9 years deep, the most recent figure standing at $20000.0 for Q4 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $20000.0 in Q4 2025; TTM through Dec 2025 was $14.1 million, a 2849.79% increase from a year earlier, with the FY2025 full-year figure at $14.1 million, up 2849.79% from the prior year.
• Other financing activities rose to $20000.0 in Q4 2025 per PLSE's latest filing, from $17000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $13.7 million in Q2 2025 and bottomed at -$14.5 million in Q3 2023.
• The 5-year median for Other financing activities is $296000.0 (2024), against an average of $130000.0.
• Across the five-year window, Other financing activities surged 6777.78% in 2021 and plunged 3090.72% in 2023, its largest moves.
• Year by year, Other financing activities stood at -$3.4 million in 2021, then soared by 85.76% to -$485000.0 in 2022, then soared by 260.0% to $776000.0 in 2023, then sank by 38.4% to $478000.0 in 2024, then sank by 95.82% to $20000.0 in 2025.
• Per Business Quant, the three latest PLSE Other financing activities figures stand at $20000.0 (Q4 2025), $17000.0 (Q3 2025), and $13.7 million (Q2 2025).